Dystrophic epidermolysis bullosa is a heritable skin disorder with dominant and recessive genetic patterns. Numerous studies underline that both forms are caused by mutations of the COL7A1 gene, which encodes collagen type VII. It has been reported that most mutations detected in the recessive disease form are nonsense mutations or small insertions or deletions leading to frameshift and premature translational termination, which tend to produce severe phenotypes. In contrast, missense mutations causing amino acid substitutions, which result in variable phenotypes, predominate in the dominant form of dystrophic epidermolysis bullosa. Genomic DNA from the patient and parents was subjected to PCR amplification of the coding region of the COL7A1 gene. Direct sequencing of the PCR products revealed a homozygous single-base deletion in the patient (c.6269-6270delC). The parents were heterozygous for the same mutation. This deletion is a novel mutation in the human COL7A1 gene based on comparisons with the Human Genome Mutation Database. To our knowledge, this is the first report of dystrophic epidermolysis bullosa in an Iranian patient confirmed by molecular diagnosis. Epidermolysis bullosa (EB) is a group of heritable and acquired skin disorders with highly variable clinical severity. The most severe forms can cause mortality during the early postnatal period, whereas milder variants are characterized by protracted skin involvement that does not influence the overall life span of the affected individuals.1 The unifying diagnostic feature of EB is skin fragility, which manifests itself as blistering and skin erosion after mechanical trauma. 2 In addition to skin symptoms, a variety of extracutaneous manifestations can be encountered in different forms of EB, including corneal erosions, enamel hypoplasia, nail dystrophy, scarring alopecia, tracheal epithelial erosion, development of esophageal strictures, and muscular dystrophy. Hereditary forms of EB include epidermolysis bullosa simplex (autosomal dominant), junctional epidermolysis bullosa (autosomal recessive), and dystrophic epidermolysis bullosa (DEB, autosomal dominant or recessive).4 DEB is characterized by sublamina densa tissue separation and abnormalities in the anchoring fibrils, which result from mutations in the COL7A1 gene and subsequent defects in type VII collagen.7 Genetic analyses of the COL7A1 gene in affected individuals revealed that most mutations detected in recessive DEB (RDEB) are nonsense mutations or small insertions or deletions leading to frameshift and a premature termination codon, which often results in severe phenotypes.8 Dominant DEB is characterized by missense COL7A1 mutations resulting in amino acid substitutions that often result in a milder disease form.9 Molecular genetic analysis of the COL7A1 gene is important for accurate diagnosis of the EB type.We present here a molecular genetic study of a young girl referred to our laboratory suspected to have EB. Despite the lack of a skin biopsy for histological examination, and based p...